ASX/MSX (ASX/MSX)

Australian Securities Exchange: ASX/MSX · AUD

A$0.05

-0.00 (-5.7%)· Recorded snapshot

Market cap	19.5M
Revenue (ttm)	402.7K
Net income (ttm)	-4.7M
EPS (ttm)	-A$0.01
Shares out	389.7M
Volume	60,597
Beta	1.23

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 402.7K
Net income (ttm): -4.7M
EPS (ttm): -A$0.01
Market cap: 19.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROE-29.7

P25 -108P50 -50.6P75 1.1

ROIC-18.5

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/MSX indicators

Market & fundamental data

Available fields

165

Groups with data

Currency

AUD

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Enterprise value	AUD 14.9M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-10-27
Fiscal year end	June
Founded	2002
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU0000012973
Last refreshed	2026-10-30
Market cap	AUD 19.5M
Price	AUD 0.05
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-30
Symbol	asx/MSX
Website	https://www.neuroscientific.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-27.83%
EV/Sales	37.11x
FCF / EV yield	-18.59%
FCF yield	-14.26%
Industry forward P/E	28.82x
P/B ratio	1.32x
P/S ratio	48.39x
Price / tangible book value	4.29x
Sector forward P/E	34.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	64.14%
Operating margin	-1,168.56%
Pretax margin	-1,165.54%
ROA	-18.3%
ROA (5Y)	-19.43%
ROCE	-31.69%
ROE	-29.68%
ROE (5Y)	-32.9%
ROIC	-18.55%
SBC / revenue	104.56%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	54,504.02%
Gross profit growth 3Y	-62.52%
Gross profit growth 5Y	-22.42%
Revenue growth (QoQ)	-73.34%
Revenue growth 3Y	-56.68%
Revenue growth 5Y	-15.93%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	AUD 1.4M
EBIT	AUD -4.7M
EBITDA	AUD -3.3M
EPS	AUD -0.01
FCF per share	AUD -0.01
Financing cash flow	AUD -30,260
Free cash flow	AUD -2.8M
Free cash flow minus SBC	AUD -3.2M
Gross profit	AUD 258,277
Investing cash flow	AUD -1.8M
Net borrowing	AUD -12,004
Net cash flow	AUD -4.6M
Net income	AUD -4.7M
Operating cash flow minus SBC	AUD -3.2M
Operating income	AUD -4.7M
Revenue	AUD 402,659
Stock-based compensation	AUD 421,028

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	65.94
Book value per share	AUD 0.04
Debt / equity	0.01
Interest coverage	-1,281.75
Long-term assets	AUD 10.4M
Long-term liabilities	AUD 38,728
Net cash (debt)	AUD 4.5M
Net cash / market cap	23.31%
Net cash growth	-37.48%
Net debt / equity	-0.31
Piotroski F-Score	1
Property, plant and equipment	AUD 86,663
Shareholders' equity	AUD 14.8M
Tangible book value	AUD 4.5M
Tangible book value per share	AUD 0.01
Total assets	AUD 15.2M
Total cash	AUD 4.6M
Total debt	AUD 87,039
Total liabilities	AUD 374,890
WACC	10.99%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.03
Current assets	AUD 4.8M
Current liabilities	AUD 336,162
Current ratio	14.27
Net working capital	AUD -119,627
Quick ratio	14.15
Working capital	AUD 4.5M
Working capital turnover	0.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-129.96%
Shareholder yield	-129.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.07
1D price change	-5.66%
1M price change	-16.67%
1M total return	-16.67%
1W price change	-10.71%
1W total return	-10.71%
1Y price change	-56.52%
1Y return CAGR	-56.55%
1Y total return	-56.52%
20-day SMA	AUD 0.06
200-day SMA	AUD 0.09
3M price change	-18.03%
3M total return	-18.03%
3Y price change	-18.03%
3Y return CAGR	-6.41%
3Y total return	-18.03%
50-day SMA	AUD 0.06
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.18
52-week high date	2026-01-14
52-week low	AUD 0.04
52-week low date	2026-10-26
5Y price change	-86.11%
5Y return CAGR	-32.62%
5Y total return	-86.11%
6M price change	-54.55%
6M total return	-54.55%
All-time high	AUD 0.54
All-time high date	2021-09-27
All-time low	AUD 0.03
All-time low date	2024-10-01
Average true range (ATR)	AUD 0.00
Average volume	129.2K
Beta (1Y)	1.74
Beta (2Y)	0.75
Beta (5Y)	1.23
Change from 52-week high	-72.22%
Change from 52-week low	21.95%
Change from all-time high	-90.74%
Change from all-time low	51.52%
Change from open	-5.66%
Day's gap	0%
Dollar volume	AUD 3,030
High price	AUD 0.05
Low price	AUD 0.05
Monthly RSI	41.68
Open price	AUD 0.05
Position in 52-week range	0%
Previous close	AUD 0.05
Price vs 150-day SMA	-33.07%
Price vs 20-day SMA	-13.19%
Price vs 200-day SMA	-42%
Price vs 50-day SMA	-17.63%
Relative volume	0.47
RSI	35.19
Sharpe ratio	-0.44
Sharpe ratio (3Y)	0.39
Sharpe ratio (5Y)	0.19
Sortino ratio	-0.66
Sortino ratio (3Y)	0.7
Sortino ratio (5Y)	0.35
Volume	60.6K
Weekly RSI	32.92
YTD price change	-54.55%
YTD total return	-54.55%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	152.6M
Shares change (QoQ)	2.43%
Shares change (YoY)	129.96%
Shares held by insiders	41.22%
Shares held by institutions	0.75%
Shares outstanding	389.7M

Deeper analysis on ASX/MSX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/MSX report

Is a complete ASX/MSX research report available?

No complete published report is available for asx/MSX (ASX/MSX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/MSX (ASX/MSX)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/MSX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/MSX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/MSX

Frequently asked questions